Home
Welcome Note
Committees
Exhibitors
Scientific Program and Abstracts
Timetable

MONDAY, MARCH 26, 2001 TUESDAY, MARCH 27, 2001 WEDNESDAY, MARCH 28, 2001
   POSTER SESSION I POSTER SESSION II

     

WEDNESDAY, MARCH 28, 2001

08:00-17:45 
P2A POSTER SESSION II POSTER AREA
Board No. VACCINES  
RISK OF DEMYELINATING DISEASE AFTER HEPATITIS B VACCINATION 
T.M. Verstraeten*, T. Verstraeten, F. Destefano, L. Jackson, P. Benson, C. Okoro, S. Black, H. Shinefield, J.
Mullooly, R. Chen, USA
 
BCG, TUBERCULIN SKIN-TEST RESULTS AND ASTHMA PREVALENCE IN SCHOOLCHILDREN IN NORTH LONDON
A. Pahari*, S. Welch, S. Lingam, UK
 
LONG-TERM FOLLOW-UP OF CHILDREN WITH HYPOTONIC HYPORESPONSIVE EPISODES (HHE) 
H. Heijbel*, K. Stjernquist, L. Gustafsson, G. Wrahme Hellstrom, P. Olin, Sweden
 
A BOOSTER STUDY OF TDCP+IPV, TDCP-IPV, OR DT+IPV AT 5 1/2 YEARS OF AGE AFTER PRIMARY IMMUNISATION WITH DTCP AT 3, 5, 12 MONTHS OF AGE
L. Gustafsson, H.O. Hallander, E. Netterlid, E. Reizenstein, P. Olin*, Sweden
 
THE BRIGHTON COLLABORATION: AN INTERNATIONAL COLLABORATIVE EFFORT TO ENHANCE COMPARABILITY OF VACCINE SAFETY DATA
J. Bonhoeffer*, K. Kohl, R. Chen, H. Heijbel, U. Heininger, T. Jefferson, E. Loupi, Switzerland
 
ACUTE CNS DISEASE AFTER VACCINATION - TEMPORAL OR CAUSAL ASSOCIATION?
M. Cizman*, M. Pokorn, M. Popovic, Slovenia
 
VACCINATION VISITS IN EARLY CHILDHOOD: JUST ONE MORE VISIT TO BE VACCINATED
E.T. Luman*, S. Stokley, D. Daniels, M. Klevens, USA
 
INADVERTENT ADMINISTRATION OF VACCINES RARELY RESULTS IN ADVERSE EVENTS
N.R.E. Kitchin*, T. Derrough, UK
 
THE IMMUNE RESPONSE OF PREMATURE INFANTS TO DTAP-HIB AND MEN-C VACCINES
M.H. Slack*, R. Thwaites, D. Schapira, C. Thornton, R. Borrow, D. Goldblatt, E. Miller, UK
 
10  APNOEAS IN PREMATURE INFANTS FOLLOWING DTAP-HIB AND MEN-C VACCINES 
M.H. Slack*, R. Thwaites, D. Schapira, E. Miller, UK
 
11  THE VACCINATION OF RISC GROUP CHILDREN SUFFERING FROM NERVOUS SYSTEM PATHOLOGY 
A. Rainyte*, S. Cirtautas, Lithuania
 
12  ANTIBODIES IN 5 1/2 YEAR OLD CHILDREN AFTER VACCINATION IN INFANCY WITH A PENTAVALENT COMBINATION VACCINE
R.M. Carlsson*, B.A. Claesson, E. Fagerlund, N. Knutsson, C.L. Lundin, Sweden
 
13  LONG TERM FOLLOW-UP OF THE HBOC EFFICACY TRIAL COHORT: NO EVIDENCE OF AN INCREASED RISK OF DIABETES ASSOCIATED WITH EARLY HIB IMMUNIZATION
E. Lewis*, H.R. Shinefield, S. Black, B. Fireman, F. Destefano, R. Chen, USA
 
14  IMMUNOGENICITY AND REACTOGENICITY OF COMBINED DTPA-HBV-IPV/HIB VACCINE COMPARED TO CONCOMITANT ADMINISTERED DTPA-HBV-IPV AND HIB VACCINES GIVEN AT 3, 5 AND 11 MONTHS
OF AGE
P. Crovari*, F. Zepp, P. Dentico, P. Habermehl, J. Huff, L. Schuerman, Italy
 
15  ANTIBODY PERSISTENCE AGAINST DIPHTHERIA, TETANUS, PERTUSSIS, POLIOMYELITIS AND HAEMOPHILUS INFLUENZAE TYPE B (HIB) IN 5-6 YEARS OLD CHILDREN
C. Thebault*, J. Langue, F. Boisnard, C. Blondeau, France
 
16  SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE LIQUID HEXAVALENT VACCINE [DTaP-IPV-Hib-HB, HEXAVAC] IN 12-18 MONTHS-OLD TODDLERS
E. Mallet*, T. Staub, F. Schodel, G. Chryssomalis, A. Hoffenbach, M. Scemama, France
 
17  WITHDRAWAL OF ORGANOMERCURIALS AS PRESERVATIVES IN VACCINES - A SLOW PROCESS 
E. Forster-Waldl*, W. Maurer, Austria
 
18  ANTIBODY AVIDIY AS A SURROGTE OF BACTERIAL CONJUGATE VACCINE INDUCED PROTECTIVE  IMMUNITY AMONG HIGH RISK SUBJECTS
V. Spoulou*, T. Victoratos, S. Grafakos, J. Ioaanidis, Greece
 
19  AUTOMATED VACCINE RECOMMENDATION FOR HEALTH CARE WORKERS: VALIDATION OF A DATABASE APPLICATION
R. Troost, K. Jahn*, M. Wagner, F. Zepp, J. Michaelis, Germany
 
20  INFLUENZA VACCINATION IN HEALTH CARE WORKERS: IMPORTANCE OF AN ACTIVE IMMUNIZATION CAMPAIGN
M. Campins*, X. Martinez, J. Elorza, N. Pinart, M. Mendez-Aguirre, E. Ferrer, Spain
 
21  EARLY ADVERSE REACTIONS AFTER VACCINATION AGAINST INFLUENZA IN CHILDREN
A. Galaj*, A. Kuziemski, L. Szadujkis-Szadurski, G. Grzesk, Poland
 
22  SAFETY AND IMMUNOGENICITY OF VAQTAŽ (HEPATITIS A VACCINE, MERCK & CO., INC.) IN HEALTHY CHILDREN 12 MONTHS OF AGE
F.A. Guerra*, A. Werzberger, K. Reisinger, S. Block, E. Walter, M. Santosham, D. Blumberg, J. Taylor, H.
Keyserling, M. Sperling, K. Eves, H. Clark, T. Grosso, B. Kuter, USA
 
23  LOW-DOSE INTRADERMAL ADMINISTRATION OF RECOMBINANT HEPATITIS B VACCINE IN CHILDREN: FIVE-YEAR FOLLOW-UP STUDY
Z. Kurugol*, S. Erensoy, S. Aksit, A. Egemen, A. Bilgic, Turkey
 
24  SEROGRUP C MENINGOCOCCAL DISEASE: EFECTIVENESS OF A MASS VACCINATION PROGRAMME AFTER 30 MONTHS OF FOLLOW-UP
L. Salleras*, A. Dominguez, P. Munoz, A. Martinez, N. Cardenosa, J. Batalla, Spain
 
25  REACTOGENICITY AND IMMUNOGENICITY OF BOOSTER AGAINST DIPHTHERIA AND TETANUS
M.L. Ciofi Degli Atti*, B. Cotter, S. Salmaso, G. Alfarone, G. Gallo, C. Von Hunolstein, Italy
 
26  COST ANALYSIS OF HEPATITIS A VACCINATION: IS PREIMMUNIZATION TEST NECESSARY?
H. Yapicioglu, A. Yaman, D. Yildizas, D. Alabaz, N. Bozdemir, N. Aksaray, E. Alhan*, Turkey
 
27  SEROEPIDEMIOLOGY OF HEPATITIS A VIRUS (HAV) ANTIBODIES AMONG CHILDREN'S HOSPITAL STAFF
G. Livni*, S. Plotkin, G. Hudik, H. Aloni, Y. Yuhas, Y. Lerman, S. Ashkenazi, Israel
 
28  COST EFECTIVENESS OF THE HEPATITIS A+B VACCINES
E. Navas*, R. Gisbert, A. Dominguez, L. Salleras, Spain
 
29  MOTHERS' PERCEPTIONS ON IMMUNIZATIONS FOR VACCINE PREVENTABLE DISEASES 
K. Mamzoridi*, E. Doulianaki, S. Gourgoulia, K. Anastasiadou, E. Maragouli, Greece
 
Board No. P2B EPIDEMIOLOGY  
30  THE IMPACT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION: A PROSPECTIVE EVALUATION IN  HOSPITALIZED INFANTS BELOW 24 MONTHS OF AGE
B. Resch*, W. Gusenleitner, W. Muller, Austria
 
31  SHORT TIME EFFECT OF PRINTED EDUCATIONAL MATERIAL ON RESPIRATORY SYNCYTIAL VIRUS DISEASE: THE START PROJECT
B. Resch*, G. Pichler, W. Gusenleitner, W. Muller, Austria
 
32  TWO-YEAR EPIDEMIC PATTERN OF RSV RELATED HOSPITALIZATIONS IN GERMANY 
J. Weigl*, W. Puppe, H.J. Schmitt, Germany
 
33  POPULATION-BASED INCIDENCE OF RSV RELATED HOSPITALIZATIONS IN CHILDREN IN GERMANY 
J. Weigl*, W. Puppe, H.J. Schmitt, Germany
 
34  VARIABILITY OF THE INCIDENCE OF HOSPITALISATION CAUSED BY INFECTION WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)
E. Rietveld*, M.A. Huysman, E.W. Steyerberg, J. Polder, R. De Groot, H.A. Moll, The Netherlands
 
35  RSV PREINFECTION ENHANCES ADHERENCE OF STREPTOCOCCUS PNEUMONIAE
J.M. Hament*, P.C. Aerts, J.L.L. Kimpen, A. Fleer, T. Harmsen, T.W.F. Wolfs, The Netherlands
 
36  EPIDEMIOLOGY OF ACUTE RESPIRATORY TRACT INFECTION VIRUSES IN CATALONIA, SPAIN
A. Dominguez*, P. Ciruela, A. Martinez, N. Torner, N. Cardenosa, G. Carmona, Spain
 
37  VIRAL LOWER RESPIRATORY TRACT INFECTION IN HOSPITALIZED INFANTS AND CHILDREN IN  GERMANY
I. Kambeck*, M. Posselt, A. Rohwedder, G. Ihorst, G. Petersen, J. Forster, Germany
 
38  VIRAL LOWER RESPIRATORY TRACT INFECTION (LRTI) IN OUTPATIENTS UP TO THE AGE OF THREE YEARS IN GERMANY (PRI.DE STUDY)
H. Gurth*, V. Legner, A. Rohwedder, H. Werchau, G. Ihorst, G. Petersen, J. Forster, Germany
 
39  EPIDEMIOLOGY OF ROTAVIRUS AND VRS INFECTIONS IN THE NORTH OF FRANCE 
O. Kremp*, F. Fakhoury, C. Spyckerelle, N. Kalach, A. Decosterr, G. Vittu, J. Cousin, France
 
40  DIARRHOEAL AND ASYMPTOMATIC ROTAVIRUS INFECTION IN UK CHILD CARE CENTRES
J. Buttery*, W.A. Sweetman, R.T. Mayon-White, M. Ramsay, R. Bishop, U. Desselberger, R. Moxon, UK
 
41  VARIATIONS IN DISEASE BURDEN OF ROTAVIRUS BETWEEN AUSTRIA, GERMANY AND SWITZERLAND IN CHILDREN WITH COMMUNITY AND NOSOCOMIALLY ACQUIRED INFECTION
U. Heininger, B. Laubereau, B. Ehlken, B. Petersen, I. Moll-Schuler, I. Mutz, W. Karmaus, J. Forster, M. Fruehwirth*, Austria
 
42  TWO YEAR PROSPECTIVE STUDY OF ROTAVIRUS INFECTION ON HOSPITALISED CHILDREN IN DUBLIN
M. Harrington*, K. Butler, M. Cafferkey, Ireland
 
43  CHANGING EPIDEMIOLOGY OF MEASLES IN ISRAEL
L.P. Rubin*, S. Rishpon, L. Barron, Israel
 
44  MUMPS SEROPREVALENCE OF CHILDREN BETWEEN AGE 1-15
Z. Siklar*, U. Tyras, A.D. Ozysyk, O. Yylmaz, G. Tanyer, O. Erdeve, H. Tezer, N. Acar, Y. Dallar, Turkey
 
45  INVESTIGATION OF A MUMPS EPIDEMIC AMONG AN ADEQUATELY IMMUNIZED MATERNAL AND PRIMARY SCHOOL POPULATION
C. Vandermeulen*, K. Hoppenbrouwers, M. Roelants, M. Vermoere, K. Rosseeuw, P. Goubau, Belgium
 
46  INTERRUPTION OF MEASLES TRASMISSION:PROGRESS IN CATALONIA,SPAIN
A. Dominguez*, N. Torner, J. Vidal, A. Martinez, L. Salleras, Spain
 
47  MATERNAL HEPATITIS A ANTIBODIES IN INFANTS
M. Hacimustafaoglu*, G. Sadikoglu, C. Zakin, S. Elebi, N. Akin, L. Turkmen, I. Ercan, G. Goral, I. Ildirim,
Turkey
 
48  HEPATITIS A PREVALENCE IN CHILDREN, IN BURSA
M. Hacimustafaoglu*, G. Sadikoglu, C. Zakin, S. Elebi, N. Akin, G. Goral, I. Ildirim, Turkey
 
49  CHILDREN'S MORBIDITY THROUGH VIRAL HEPATITIS A IN THE REPUBLIC OF MOLDOVA
P. Iarovoi*, M. Isac, Moldova
 
50  EVALUATION OF ANTENATAL SCREENING FOR HEPATITIS B VIRUS IN DENMARK 
L. Jensen*, C. Heilmann, E. Smith, P. Wantzin, B. Peitersen, T. Weber, K. Krogsgaard, Denmark
 
51  SEROPREVALENCE OF HUMAN HERPES VIRUSES HSV1, HSV2 , VZV AND HHV6 IN ISRAELI POPULATION
M. Isacsohn*, Z. Smetana, Z.Z. Rones, Y. Amir, D. Raveh, B. Rudensky, I. Schlesinger, M. Alkin, Z. Supaev, M.
Book, P. Slater, Israel
 
52  EPIDEMIOLOGY OF MATERNAL CMV SERONEGATIVE STATUS IN PREGNANCY IN THE UK
M. Khare*, M. Sharland, I. Manyonda, P. Griffiths, UK
 
53  STREPTOCOCCUS PNEUMONIAE MENINGITIS IN CHILDREN
J. Kavaliotis*, A. Nanou, S. Petridou, Greece
 
54  INVASIVE PNEUMOCOCCAL DISEASE (IPD) AT A CHILDREN´S HOSPITAL IN COSTA RICA
C.M. Odio*, M.L. Herrera, I. Yock, Costa Rica
 
55  EPIDEMIOLOGY OF INVASIVE PNEUMOCOCCAL DISEASE IN INFANTS IN CATALONIA (SPAIN) 
A. Dominguez*, P. Ciruela, A. Martinez, G. Carmona, N. Torner, N. Cardenosa, L. Salleras, Spain
 
56  SURVEILLANCE OF INVASIVE PNEUMOCOCCAL DISEASE IN THE PEDIATRIC POPULATION OF GERMANY, 1997-1999
R.R. Reinert*, A. Siedler, A. Al-Laham, R. Luetticken, R. Von Kries, Germany
 
57  PNEUMOCOCCAL VACCINE SEROTYPES ISOLATED FROM ARGENTINIAN CHILDREN WITH INVASIVE DISEASE
S.E. Gonzalez Ayala, M. Regueira, M.R. Agosti*, M.P. Pascual, C. Vescina, M. Altschuler, Argentina
 
58  THE PROJECTED IMPACT OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN THE UNITED KINGDOM
K.E. Hvidsten*, S. Arikian, V. Ciuryla, P. Conway, R. Casciano, R. Krishnaswamy, USA
 
59  BACTERIAL MENINGITIS IN NORTHERN GREECE: CAUSATIVE AGENTS AND COURSE OF THE DISEASE (1970-1999)
J. Kavaliotis*, S. Petridou, A. Nanou, E. Zevgaridou, A. Efthimiou, A. Kansouzidou, H. Tsagaropoulou, Greece
 
60  HAEMOPHILUS INFLUENZAE TYPE B MENINGITIS: 30 YEARS EXPERIENCE 
J. Kavaliotis*, A. Efthimiou, E. Zevgaridou, Greece
 
61  MENINGOCOCCAL SEPTICAEMIA IN NORTHERN GREECE 
J. Kavaliotis*, K. Kontouli, M. Toumba, S. Savvas, Greece
 
62  ETHNICITY AND DIFFERENCES IN CLINICAL PRESENTATION AND DISEASE SEVERITY IN CHILDREN WITH MENINGEAL SIGNS
C.B. Bouwhuis*, R. Oostenbrinck, K.G.M. Moons, H.A. Moll, The Netherlands
 
63  MENINGOCOCCAL MENINGITIS: EPIDEMIOLOGICAL AND CLINICAL DATA (1970-1999) 
S. Petridou*, E. Zevgaridou, A. Efthimiou, A. Nanou, J. Kavaliotis, Greece
 
64  A STUDY OF BACTERIAL MENINGITIS IN FIVE HOSPITALS IN PORTUGAL 
M. Vasconcelos*, S. Lemos, G. Rocha, Portugal
 
65  REFERRAL OF CHILDREN WITH MENINGOCOCCAL DISEASE (MD) FOR INTENSIVE CARE: A DISTRICT GENERAL HOSPITAL (DGH) PERSPECTIVE OVER A DECADE (1990-2000)
P. Ramnarayan*, J. Bose, J. Britto, UK
 
66  HOUSEHOLD CROWDING A MAJOR RISK FACTOR FOR EPIDEMIC MENINGOCOCCAL DISEASE IN AUCKLAND CHILDREN
M. Baker, A. McNicholas, N. Garrett, N. Jones, J. Stewart, V. Koberstein, D.R. Lennon*, New Zealand
 
67  BEHAVIOUR AND MENINGOCOCCAL DISEASE IN TEENAGERS 
P.G. Coen*, J. Tully, R. Viner, J. Stuart, R. Booy, UK
 
68  A CZECH MULTICENTER PROSPECTIVE SURVEY OF BACTERIAL ACUTE OTITIS MEDIA IN YOUNG CHILDREN
R. Prymula*, P. Krizova, V. Chrobok, P. Peeters, Czech Republic
 
69  THE CARRIAGE RATE OF GROUP A, C AND G STREPTOCOCCI IN THROAT AMONG HEALTY SCHOOLCHILDREN IN ELAZIG, TURKEY
K. Demirdag*, Y. Dogan, M. Ozden, Y. Sen, D. Aygun, A. Kalkan, Turkey
 
70  A PAEDIATRIC SENTINEL NETWORK FOR THE SURVEILLANCE OF VACCINE-PREVENTABLE DISEASES IN ITALY
M.L. Ciofi Degli Atti*, S. Salmaso, M. Gangemi, G. Chiamenti, G. Brusoni, Italy
 
71  SEASONAL VARIATION OF ADMISSIONS TO A PAEDIATRIC INFECTIOUS DISEASES UNIT AT A LISBON HOSPITAL
J. Charlton, P. Correia*, J.G. Marques, A. Mousinho, M. Pinheiro, P. Valente, Portugal
 
72  THE USE OF ANTIMICROBIALS IN A PEDIATRIC OUTPATIENT CLINIC
P. Kaltenis*, Lithuania
 
Board No. P2C DIAGNOSIS  
73  MOLECULAR DIAGNOSIS OF MEDITERRANEAN SPOTTED FEVER BY POLYMERASE CHAIN REACTION
D. Wachtel*, Y. Schlesinger, D. Halle, B. Rudensky, A. Liddell, T. Wilson, G.A. Storch, Israel
 
74  COMPARISON OF RSV DETECTION BY RSV-ANTIGEN-ELISA AND MULTIPLEX PCR IN LOWER RESPIRATORY TRACT INFECTIONS IN CHILDREN
J. Bittscheidt*, A. Rohwedder, J. Schwarze, J. Forster, G. Petersen, H. Werchau, V. Stephan, Germany
 
75  DEVELOPMENT OF A TYPE-SPECIFIC MULTIPLEX PCR FOR STREPTOCOCCUS PNEUMONIAE
A. Saukkoriipi*, D.C. Miller, L. Kuisma, M. Leinonen, J.C. Paton, Finland
 
76  CLINICAL AND LABORATORY MARKERS FOR BORDETELLA INFECTION IN A HIGHLY VACCINATED POPULATION
I. Srugo*, D. Benilevi, S. Shapiro, V. Gershtein, R. Gershtein, M. Jaffe, R. Madeb, L. Rubin, N. Lahat, Israel
 
77  DEMONSTRATION OF STREPTOCOCCUS PNEUMONIAE BY CULTURE AND PCR IN THE MIDDLE EAR FLUID OF CHILDREN WITH ACUTE OTITIS MEDIA
A. Saukkoriipi*, S. Rintamaki, P. Salo, T. Kaijalainen, R. Syrjanen, A. Takala, M. Leinonen, Finland
 
78  SERUM AMYLOID A PROTEIN (SAA) IN THE ASSESMENT OF SEVERITY OF INFECTIOUS DISEASES IN CHILDREN; COMPARISON WITH SERUM C - REACTIVE PROTEIN (CRP)
T. Huttunen*, A.M. Teppo, P. Ruutu, S. Lupisan, H. Nohynek, Finland
 
79  PROCALCITONIN AS A PROGNOSTIC PARAMETER IN MENINGOCOCCAL DISEASE 
D.C.M. Van Der Kaay*, E.D. De Kleijn, P.G.J. Ter Heerdt, W.C.J. Hop, R. De Groot, J.A. Hazelzet, The
Netherlands
 
80  CEREBROSPINAL FLUID TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-6 FOR THE DIAGNOSIS OF ACUTE BACTERIAL MENINGITIS IN CHILDREN
A.B. Cengiz*, G. Kanra, G. Secmeer, M. Ceyhan, B. Kara, Turkey
 
81  FECAL LACTOFERRIN IN THE DIAGNOSIS OF INVASIVE CHILDHOOD DIARRHEA 
A. Kara*, G. Kanra, G. Secmeer, M. Ceyhan, A.B. Cengiz, Turkey
 
82  PROSPECTIVE USE OF PROCALCTONIN TO REDUCE ANTIBIOTIC TREATMENTS DURING AN OUTBREAK OF VIRAL MENINGITIS
C. Menager, E. Marc, F. Moulin, P. Lebon, S. Guerin, C. Bohuon, J. Raymond, D. Gendrel*, France
 
83  THE SIGNIFICANCE OF FEVER IN CHILDREN
Z. Nademi*, J.E. Clark, C. Richards, D. Walshaw, A.J. Cant, UK
 
84  THE USEFULNESS OF PROCALCITONIN IN DIAGNOSING INFECTION IN IMMUNOCOMPROMISED CHILDREN
Z. Nademi*, J.E. Clark, A.J. Cant, S. Hoare, A. Weddell, D. Walshaw, UK
 
85  DIAGNOSIS OF ACUTE HEMATOGENOUS OSTEOMYELITIS AND SEPTIC ARTHRITIS: A 20 YEAR EXPERIENCE AT THE UNIVERSITY CHILDREN'S HOSPITAL BASEL
J. Bonhoeffer*, B. Haeberle, U.B. Schaad, U. Heininger, Switzerland
 
86  DIAGNOSTIC RESEARCH IN CLINICAL PRACTICE: PROSPECTS AND PROBLEMS
R. Oostenbrink*, S.E. Bleeker, D.E. Grobbee, H.A. Moll, K.G. Moons, The Netherlands
 
87  ACCEPTABILITY OF SCREENING FOR PRIMARY MATERNAL CYTOMEGALOVIRUS INFECTION DURING PREGNANCY BY URINE POLYMERASE CHAIN REACTION (PCR)
M. Khare*, M. Sharland, I. Manyonda, P. Griffiths, UK
 
Board No. P2D IMMUNOLOGY  
88  IMMUNOLOGICAL EVALUATION OF CHILDREN WITH RECURRENT ACUTE OTITIS MEDIA 
R.H. Veenhoven*, A.G.M. Schilder, G.T. Rijkers, C.S.P.M. Uiterwaal, W. Kuis, E.A.M. Sanders, The Netherlands
 
89  CHARACTERISTICS OF AN ANTIBODY RESPONSE TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES IN YOUNG CHILDREN WITH ACUTE OTITIS MEDIA
A. Soininen*, M. Lahdenkari, M. Voutilainen, T. Kilpi, P.H. Makela, H. Kayhty, Finland
 
90  PLACENTAL TRANSFER OF MEASLES ANTIBODIES IN PRETERM INFANTS
A. Barzilai*, B. German, P. Duvdevani, E. Mendelson, A. Ferber, E. Tallen-Gozani, L. Lirota, D. Prais, N.
Linder, Israel
 
91  PLASMA MATRIX METALLOPROTEINASES (MMP)-9 AND MMP-2: A ROLE IN THE PATHOPHYSIOLOGY OF MENINGOCOCCAL DISEASE?
E.D. Carrol*, S.D. Carter, D.R. Isherwood, A.P. Thomson, J.A. Sills, C.A. Hart, UK
 
92  COMPLEMENT LEVELS FOLLOWING MENINGOCOCCAL DISEASE - NO NEED TO MEASURE ROUTINELY
S. Hoare*, O. El-Shazali, A. Fay, A.J. Cant, UK
 
93  ACTIVATION OF NUCLEAR FACTOR-KAPPAB AND INDUCTION OF INDUCIBLE NITRIC OXIDE SYNTHASE BY UREAPLASMA UREALYTICUM IN MACROPHAGES
Y.H. Li, Z. Yan, J. Skov Jensen, A. Brauner, K. Tullus*, Sweden
 
94  THE IMMUNOLOGICAL EFFECT OF DIETARY FISH-OIL AND LEUKOTRIENE METABOLISM
A. Haraldsson*, V.S. Thors, H. Erlendsottir, I. Harardottir, E. Gunnarsson, Iceland
 
95  IMMUNITY TO DIPHTHERIA IN IZMIR, TURKEY
A. Egemen*, Z. Kurugol, T. Ozacar, P. Keskinoglu, S. Aksit, I. Afsar, I. Akil, Turkey
 
Board No. P2E IMMUNOCOMPROMIZED HOST  
96  CENTRAL VENOUS CATHETER (CVC) - RELATED INFECTIONS IN CHILDREN: COMPARISON BETWEEN PRIMARY IMMUNODEFICIENCIES AND MALIGNANCIES
R.F. Schumacher*, C. Offer, E. Draghin, A. Arrighini, F. Porta, L.D. Notarangelo, Italy
 
97  GENERALIZED ZOSTER AFTER BMT FOR T-CELL LEUKEMIA
R.F. Schumacher*, L. Notaranglo, A. Chiodera, E. Mazzolari, Italy
 
98  SEPTIC ARTHRITIS DUE TO SALMONELLA ENTERITIDIS IN A PATIENT WITH SYSTEMIC LUPUS
ERYTHEMATOSUS (SLE)

C.M. Gebauer*, M. Borte, R. Schille, R. Scholz, V. Schuster, W. Handrick, Germany
 
99  ANTIVIRAL PROPHYLAXIS IN CHILHOOD CANCER
T. Celkan*, T. Celkan, H. Apak, I. Yildiz, L. Yuksel, A. Ozkan, S. Diren, Y. Camcioglu, Turkey
 
100  BACTERIEMIA IN CHILDHOOD CANCER
L. Yuksel*, T. Celkan, H. Apak, A. Ozkan, S. Diren, I. Yildiz, Turkey
 
101  A DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A SEVEN VALENT CONJUGATE PNEUMOCOCCAL (PCV) VACCINE IN HIV INFECTED INFANTS
S.A. Nachman*, S. Kim, J. King, USA
 
102  SERONEGATIVE HIV-1 INFECTION LEADS TO DELAYED DIAGNOSIS AND INSUFFICIENT VIRAL LOAD DECREMENT
P.L.A. Fraaij*, A.M.C. Van Rossum, K.K.C. Wolthers, Y.C.M. Jeucken, N.N.G. Hartwig, R. De Groot, The
Netherlands
 
103  MEASUREMENT OF ZIDOVUDINE TRIPHOSPHATE (AZT-TP) WITH MATRIX ASSISTED LASER DESORPTION/IONIZATION (MALDI) MASS SPECTROSCOPY
J.J.A. Van Kampen*, P.L.A. Fraaij, T.M. Luider, R. De Groot, The Netherlands
 
104  INDINAVIR ASSOCIATED ASYMPTOMATIC NEPHROLITHIASIS AND RENAL CORTEX ATROPHY IN TWO HIV-1 INFECTED CHILDREN
A. Van Rossum*, J.P. Dieleman, P.L.A. Fraaij, I.C. Gyssens, K. Cransberg, N.G. Hartwig, R. De Groot, The
Netherlands
 
105  ATYPICAL PRESENTATION OF CONGENITAL HIV INFECTION
R.F. Schumacher*, E. Mazzolari, P. Biban, P. Carrara, M. Duse, Italy
 

top of page

designed by